SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-020862
Filing Date
2024-05-07
Accepted
2024-05-07 08:50:20
Documents
71
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q espr-20240331.htm   iXBRL 10-Q 964492
2 EX-10.1 exhibit101settlementagreem.htm EX-10.1 64656
3 EX-10.2 a1023rdamendmentdse.htm EX-10.2 131459
4 EX-10.3 a103ds1stamendment.htm EX-10.3 142018
5 EX-31.1 espr-ex311x03312024.htm EX-31.1 10921
6 EX-31.2 espr-ex312x03312024.htm EX-31.2 10990
7 EX-32.1 espr-ex321x03312024.htm EX-32.1 8276
  Complete submission text file 0001628280-24-020862.txt   6647440

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT espr-20240331.xsd EX-101.SCH 61604
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT espr-20240331_cal.xml EX-101.CAL 52347
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT espr-20240331_def.xml EX-101.DEF 299418
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT espr-20240331_lab.xml EX-101.LAB 624272
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT espr-20240331_pre.xml EX-101.PRE 446451
75 EXTRACTED XBRL INSTANCE DOCUMENT espr-20240331_htm.xml XML 731748
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35986 | Film No.: 24919821
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)